68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate

被引:8
|
作者
Qiu, Shuang [1 ]
Dong, Aisheng [1 ]
Zhu, Yan [2 ]
Zuo, Changjing [1 ]
机构
[1] Navy Med Univ, Changhai Hosp, Dept Nucl Med, 168 Changhai Rd, Shanghai 200433, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China
关键词
prostatic ductal adenocarcinoma; PSMA; FDG; PET/CT;
D O I
10.1097/RLU.0000000000004230
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Prostatic ductal adenocarcinoma is an uncommon variant of prostatic carcinoma with aggressive behavior and worse prognosis. We describe Ga-68-PSMA-11 and FDG PET/CT findings in a case of prostatic ductal adenocarcinoma with pelvic lymph node metastases. The majority of the prostate tumor and all the metastatic lesions showed no significant PSMA uptake but intense FDG uptake. The role of PSMA and FDG PET in the management of prostatic ductal adenocarcinoma needs to be investigated in a large number of patients.
引用
收藏
页码:836 / 838
页数:3
相关论文
共 50 条
  • [41] 68Ga-PSMA-11 dynamic PET/CT in the diagnostics of primary prostate cancer
    Sachpekidis, C.
    Eder, M.
    Kopka, K.
    Mier, W.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S669 - S669
  • [42] A Comprehensive Safety Evaluation of 68Ga-PSMA-11 PET/CT in Prostate Cancer
    Nielsen, Julie B.
    Zacho, Helle D.
    Haberkorn, Uwe
    Nielsen, Karin M.
    Dettmann, Katja
    Langkilde, Niels C.
    Petersen, Lars J.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (07) : 520 - 524
  • [43] 68Ga-PSMA-11 dynamic PET/CT in biochemical relapse of prostate cancer
    Sachpekidis, C.
    Eder, M.
    Kopka, K.
    Mier, W.
    Hadaschik, B. A.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S670 - S670
  • [44] 68Ga-PSMA Versus 18F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma
    Senses, Veysi
    Kaplan, Ihsan
    Kaya, Fulya
    Ibiloglu, Ibrahim
    Can, Canan
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : e464 - e467
  • [45] 18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging
    van Leeuwen, Pim J.
    Emmett, Louise
    EUROPEAN UROLOGY, 2022, 82 (05) : 510 - 511
  • [46] PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive
    Gauthe, M.
    Belissant, O.
    Girard, A.
    Yin, J. Zhang
    Ohnona, J.
    Cottereau, A. -S.
    Nataf, V.
    Balogova, S.
    Pontvert, D.
    Lebret, T.
    Guillonneau, B.
    Cussenot, O.
    Talbot, J. -N.
    PROGRES EN UROLOGIE, 2017, 27 (8-9): : 474 - 481
  • [47] Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT
    Cai, Jiayu
    Xu, Weizhi
    Meng, Tinghua
    Pang, YiZhen
    Chen, Haojun
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (08) : 743 - 745
  • [48] Diagnostic value of 18F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET/CT
    Chen, Ruohua
    Wang, Yining
    Shi, Yiping
    Zhu, Yinjie
    Xu, Lian
    Huang, Gang
    Liu, Jianjun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (09) : 2970 - 2977
  • [49] Diagnostic value of 18F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET/CT
    Ruohua Chen
    Yining Wang
    Yiping Shi
    Yinjie Zhu
    Lian Xu
    Gang Huang
    Jianjun Liu
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2970 - 2977
  • [50] 68Ga-PSMA PET/CT Detecting Metastatic Lesion of RCC Missed on 18F-FDG PET/CT
    Jha, Saurav
    Hemrom, Angel
    Shamim, Shamim Ahmed
    Barwad, Adarsh
    Batra, Atul
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) : E294 - E296